Abstract:The adsorption of biomolecules to the surface of nanoparticles (NPs) following administration into biological environments is widely recognized. In particular, the "protein corona" is well understood in terms of formation kinetics and impact upon the biological interactions of NPs. Its presence is an essential consideration in the design of therapeutic NPs. In the present study, the protein coronas of six polymeric nanoparticles of prospective therapeutic use were investigated. These included three colloidal NPs-soft core-multishell (CMS) NPs, plus solid cationic Eudragit RS (EGRS), and anionic ethyl cellulose (EC) nanoparticles-and three nanogels (NGs)-thermoresponsive dendritic-polyglycerol (dPG) nanogels (NGs) and two amino-functionalized dPG-NGs. Following incubation with human plasma, protein coronas were characterized and their biological interactions compared with pristine NPs. All NPs demonstrated protein adsorption and increased hydrodynamic diameters, although the solid EGRS and EC NPs bound notably more protein than the other tested particles. Shifts toward moderately negative surface charges were also observed for all corona bearing NPs, despite varied zeta potentials in their pristine states. While the uptake and cellular adhesion of the colloidal NPs in primary human keratinocytes and human umbilical vein endothelial cells were significantly decreased when bearing the protein corona, no obvious impact was seen in the NGs. By contrast, corona bearing NGs induced marked increases in cytokine release from primary human macrophages not seen with corona bearing colloidal NPs. Despite this, no apparent enhancement to in vitro toxicity was noted. Finally, drug release from EGRS and EC NPs was assessed, where a decrease was seen in the EGRS NPs alone. Together these results provide a direct comparison of the physical and biological impact the protein corona has on NPs of widely varied character and in particular highlights a distinction between the corona's effects on NGs and colloidal NPs.

Unveiling the challenges of engineered protein corona from the proteins' perspective

The Protein Corona on Nanoparticles As Viewed from a Nanoparticle‐sizing Perspective

The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.

Towards understanding of nanoparticle–protein corona

The protein corona from nanomedicine to environmental science

A Review for Uncovering the "Protein-Nanoparticle Alliance": Implications of the Protein Corona for Biomedical Applications

An Overview of Nanoparticle Protein Corona Literature

The Impact of Protein Corona on the Behavior and Targeting Capability of Nanoparticle-Based Delivery System.

Protein Corona Formation Around Nanoparticles – from the Past to the Future

Nanoparticle protein corona: from structure and function to therapeutic targeting

Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

Characterization and Biomedical Application Opportunities of the Nanoparticle's Protein Corona

Perspectives on Protein-Nanoparticle Interactions at the <i>In Vivo</i> Level

A health concern regarding the protein corona, aggregation and disaggregation

In situ characterization techniques of protein corona around nanomaterials

Protein Corona: Challenges and Opportunities for Targeted Delivery of Nanomedicines

Role of protein corona in the biological effect of nanomaterials: Investigating methods

Protein corona, influence on drug delivery system and its improvement strategy: A review

Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties

The protein corona and its effects on nanoparticle-based drug delivery systems

The Yin and Yang of the protein corona on the delivery journey of nanoparticles